LITHOBID Drug Patent Profile
✉ Email this page to a colleague
When do Lithobid patents expire, and when can generic versions of Lithobid launch?
Lithobid is a drug marketed by Ani Pharms and is included in one NDA.
The generic ingredient in LITHOBID is lithium carbonate. There are fifteen drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the lithium carbonate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lithobid
A generic version of LITHOBID was approved as lithium carbonate by HIKMA on January 29th, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LITHOBID?
- What are the global sales for LITHOBID?
- What is Average Wholesale Price for LITHOBID?
Summary for LITHOBID
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 133 |
| Clinical Trials: | 13 |
| Patent Applications: | 2,019 |
| Drug Prices: | Drug price information for LITHOBID |
| What excipients (inactive ingredients) are in LITHOBID? | LITHOBID excipients list |
| DailyMed Link: | LITHOBID at DailyMed |
Recent Clinical Trials for LITHOBID
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| William V. Bobo, M.D. | Phase 2 |
| Columbia University | Phase 2 |
| Alzheimer's Drug Discovery Foundation | Phase 2 |
Pharmacology for LITHOBID
| Drug Class | Mood Stabilizer |
US Patents and Regulatory Information for LITHOBID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ani Pharms | LITHOBID | lithium carbonate | TABLET, EXTENDED RELEASE;ORAL | 018027-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LITHOBID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Ani Pharms | LITHOBID | lithium carbonate | TABLET, EXTENDED RELEASE;ORAL | 018027-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
